Back to search

Ireland· IE-PA-PA1217/010/002

Teicoplanin Hikma 400 mg Powder for solution for injection/infusion or oral solution

A teicoplanin product containing teicoplanin, registered in Ireland by Hikma Farmacêutica (Portugal) S.A.. The same ATC class is registered in 15 of our 19 countries.

ATC J01XA02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedTeicoplanin Hikma 400 mg Powder for s…ATCJ01XA02REGISTER NO.IE-PA-PA1217/010/002PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Teicoplanin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01XA02 (teicoplanin), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Teicoplanin · ATC J01XA02

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Teicoplanin
Manufacturer
Hikma Farmacêutica (Portugal) S.A.
Country
Ireland (IE)
ATC code
J01XA02
ATC class
Teicoplanin
Defined daily dose
0.4 g, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1217/010/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Teicoplanin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All teicoplanin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Teicoplanin Accord, Teicoplanin Altan
  • Belgium · Targocid, Teicoplanin Bradex
  • Bulgaria · Планитек, Планицид
  • Cyprus · Talinac, Teicoplanin Aptapharma
  • Czechia · Targocid, Teicoplanin Aptapharma
  • Germany · Teicoplanin Altan, Teicoplanin Centurion
  • Denmark · Targocid, Teicoplanin Demo S.A.
  • Spain · Targocid, Teicoplanina Accord
  • Finland · Targocid, Teicoplanin Demo S.A.
  • France · Targocid, Teicoplanine Altan
  • United Kingdom (Northern Ireland) · Targocid, Teicoplanin
  • Greece · Talinac, Targocid
  • Croatia · Targocid, Teikoplanin Aptapharma
  • Hungary · Targocid, Teicoplanin Anfarm
  • Italy · Planicid, Targosid
  • Luxembourg · Targocid
  • Malta · Targocid, Teicoplanin Anfarm
  • Netherlands · Targocid, Teicoplanin Sun
  • Norway · Teicoplanin Demo S.A.
  • Poland · Targocid, Teicoplanin Altan
  • Portugal · Teicoplanina Accord, Teicoplanina Altan
  • Romania · Targocid, Teicoplanină Aptapharma
  • Sweden · Targocid, Teicoplanin Bradex
  • Slovenia · Targocid, Teikoplanin Aptapharma
  • Slovakia · Targocid, Teicoplanin Aptapharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0b762cc-7feb-447f-9922-f5ba22205375
GET /v1/drugs/d0b762cc-7feb-447f-9922-f5ba22205375?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection/infusion",
  "routes": [
    "Intramuscular use",
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01XA",
    "J01XA02"
  ],
  "strength": null,
  "pa_number": "PA1217/010/002",
  "substances": [
    "Teicoplanin"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "06/04/2018",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about teicoplanin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.